SAVA
The company develops a minimally invasive, multi-molecule biosensor platform designed for continuous health monitoring. The device measures molecules such as glucose, lactate, and ketones just below the skin to provide real-time data to a connected smartphone app. The technology targets individuals managing chronic conditions like diabetes as well as those focused on general wellbeing.
Visit websiteLondon, UK
Healthtech
Medical Devices
Biotechnology
Healthcare
Funding summary
- Total raised
- €24.1M
- Funding rounds
- 2
Investors in SAVA
Investors on record for SAVA. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like SAVA?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors